Xaira Therapeutics Completes $1 Billion Series A Funding to Advance AI Drug Discovery

Xaira Therapeutics, a San Francisco-based company that is using AI to advance drug discovery, raised $1 billion in a Series A round in April led by Foresite Capital and ARCH Venture Partners.